SFXN1 and acute respiratory distress syndrome: In two adult patients on ECMO for acute respiratory distress syndrome (ARDS), Vallhonrat et al., described rapid elevations in the levels of C3b and terminal complement complex (TCC) (fluid-phase MAC), which were evident within 15 minutes of commencing ECMO.